Health Canada has authorized pharmaceutical company Moderna to move forward with a clinical trial for an mRNA vaccine targeting the Ebola virus strain currently fuelling an explosive outbreak abroad.
Canada is now the second country to authorize a Phase I clinical trial for a Bundibugyo virus vaccine candidate after the U.K., according to federal officials in a news release.
There is currently no licensed vaccine or treatment for Bundibugyo virus disease, the strain of Ebola disease that is responsible for the current outbreak in the Democratic Republic of the Congo. There have been no cases of Ebola disease in Canada.
Participants in the…
Read the full article at GLOBALNEWS.CA
